Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,541 to 1,560 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts. | Clin Epigenetics | 2020 | 32664951 | PubTator, text mining | PubMed |
| The Hippo Pathway in Cardiac Regeneration and Homeostasis: New Perspectives for Cell-Free Therapy in the Injured Heart. | Biomolecules | 2020 | 32664346 | PubTator, text mining | PubMed |
| PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling. | Mol Cell Probes | 2020 | 32645410 | PubTator, text mining | PubMed |
| Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer. | Acta Pharm Sin B | 2020 | 32642404 | PubTator, text mining | PubMed |
| p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth. | Oncogene | 2020 | 32641858 | PubTator, text mining | PubMed |
| MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation. | Cell Rep | 2020 | 32640226 | PubTator, text mining | PubMed |
| Circular RNAs: Promising Molecular Biomarkers of Human Aging-Related Diseases via Functioning as an miRNA Sponge. | Mol Ther Methods Clin Dev | 2020 | 32637451 | PubTator, text mining | PubMed |
| The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma. | Cancers (Basel) | 2020 | 32629964 | PubTator, text mining | PubMed |
| Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells. | iScience | 2020 | 32623336 | PubTator, text mining | PubMed |
| [Emerging roles of Hippo signaling pathway in gastrointestinal cancers and its molecular mechanisms]. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2020 | 32621422 | PubTator, text mining | PubMed |
| YAP1 Promotes Tumor Invasion and Metastasis in Nasopharyngeal Carcinoma with Hepatitis B Virus Infection. | Onco Targets Ther | 2020 | 32606777 | PubTator, text mining | PubMed |
| A Novel Serum Exosomes-Based Biomarker hsa_circ_0002130 Facilitates Osimertinib-Resistance in Non-Small Cell Lung Cancer by Sponging miR-498. | Onco Targets Ther | 2020 | 32606748 | PubTator, text mining | PubMed |
| The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma. | Cancer Sci | 2020 | 32589311 | PubTator, text mining | PubMed |
| HERC Ubiquitin Ligases in Cancer. | Cancers (Basel) | 2020 | 32580485 | PubTator, text mining | PubMed |
| A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation. | Cancers (Basel) | 2020 | 32575464 | PubTator, text mining | PubMed |
| Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations. | Cancers (Basel) | 2020 | 32570879 | PubTator, text mining | PubMed |
| Circular RNAs in gastric cancer: Biomarkers for early diagnosis. | Oncol Lett | 2020 | 32565971 | PubTator, text mining | PubMed |
| Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal. | Oncogene | 2020 | 32561852 | PubTator, text mining | PubMed |
| MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer. | PLoS Pathog | 2020 | 32555725 | PubTator, text mining | PubMed |
| Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. | Nat Rev Drug Discov | 2020 | 32555376 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=78